FDA Inspection 1265571 — Gabor Kovacs, M.D., Ph. D.
The FDA completed an inspection of Gabor Kovacs, M.D., Ph. D. on March 12, 2025 in Budapest. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Budapest (Hungary)
Additional Details
Clinical Investigator (CI)